Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Tuesday, July 29, 2025

Lucintel Forecasts the Global Sonodynamic Therapy Market to Grow with a CAGR of 12.3% from 2025 to 2031

According to a market report by Lucintel, the future of the global sonodynamic therapy market looks promising with opportunities in the recurrent glioblastoma and diffuse intrinsic pontine glioma markets. The global sonodynamic therapy market is expected to grow with a CAGR of 12.3% from 2025 to 2031. The major drivers for this market are the increasing prevalence of cancer and the rising research & development in sonodynamic therapy.

A more than 150-page report to understand trends, opportunity and forecast in global sonodynamic therapy market to 2031 by type (device and drug), application (recurrent glioblastoma, diffuse intrinsic pontine glioma, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that, within the type category, device will remain larger segment over the forecast period due to primary role of ultrasound devices in sonodynamic therapy.

Within the application category, recurrent glioblastoma is expected to witness the higher growth due to high prevalence of cancer.

Download sample by clicking on sonodynamic therapy market

In terms of region, North America is expected to witness the highest growth over the forecast period.

SonALAsense, Alpheus Medical, Photolitec, CureMetrix, Philips Healthcare are the major suppliers in the sonodynamic therapy market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. +1-972-636-5056

Explore Our Latest Publications

Renal Replacement Therapy Market

Paraffin Physical Therapy Market

Palladium Silver Target Market

Pain Light Therapy Device Market

Network Video Encoder Market

 

No comments:

Post a Comment